Abstract
A large number of tumor suppressor genes have been identified in Drosophila. Mutations in these genes cause effects in a wide range of tissues resulting in hyperplastic and, in the case of a few specific genes, neoplastic growth. The study of these tumors can provide molecular and cellular information that may shed some light on the possible mechanisms of tumorigenesis and invasiveness of human tumor cells. Recently, several studies have shown links between homologs of Drosophila tumor suppressor genes and human cancer. These recent advances are reviewed.
Keywords: tumor suppressor, drosophila, neoplasia, lgl, dlg, scrib
Current Genomics
Title: Drosophila Neoplasias: Clues Towards the Understanding of Human Cancers
Volume: 6 Issue: 4
Author(s): E. C. Woodhouse and L. A. Liotta
Affiliation:
Keywords: tumor suppressor, drosophila, neoplasia, lgl, dlg, scrib
Abstract: A large number of tumor suppressor genes have been identified in Drosophila. Mutations in these genes cause effects in a wide range of tissues resulting in hyperplastic and, in the case of a few specific genes, neoplastic growth. The study of these tumors can provide molecular and cellular information that may shed some light on the possible mechanisms of tumorigenesis and invasiveness of human tumor cells. Recently, several studies have shown links between homologs of Drosophila tumor suppressor genes and human cancer. These recent advances are reviewed.
Export Options
About this article
Cite this article as:
Woodhouse C. E. and Liotta A. L., Drosophila Neoplasias: Clues Towards the Understanding of Human Cancers, Current Genomics 2005; 6 (4) . https://dx.doi.org/10.2174/1389202054395946
DOI https://dx.doi.org/10.2174/1389202054395946 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Genomic Insights into Oncology: Harnessing Machine Learning for Breakthroughs in Cancer Genomics.
This special issue aims to explore the cutting-edge intersection of genomics and oncology, with a strong emphasis on original data and experimental validation. While maintaining the focus on how machine learning and advanced data analysis techniques are revolutionizing our understanding and treatment of cancer, this issue will prioritize contributions that ...read more
Integrating Artificial Intelligence and Omics Approaches in Complex Diseases
Recent advancements in AI and omics methodologies have revolutionized the landscape of biomedical research, enabling us to extract valuable information from vast amounts of complex data. By combining AI algorithms with omics technologies such as genomics, proteomics, metabolomics, and transcriptomics, researchers can obtain a more comprehensive and multi-dimensional analysis of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Efficacy of PD-1 or PD-L1 Inhibitors and Central Nervous System Metastases in Advanced Cancer: A Meta-Analysis
Current Cancer Drug Targets The Long and Winding Road to Cancer Treatment: The Trail System
Current Pharmaceutical Design Anti-Angiogenic Therapies in the Treatment of Waldenstrom's Macroglobulinemia
Current Cancer Drug Targets Overview of Current Immunotherapies Targeting Mutated KRAS Cancers
Current Topics in Medicinal Chemistry Pharmacogenetics, Pharmacogenomics and Epigenetics of Nrf2-regulated Xenobioticmetabolizing Enzymes and Transporters by Dietary Phytochemical and Cancer Chemoprevention
Current Drug Metabolism Structure and Dynamics of Cardiotoxins
Current Protein & Peptide Science Hydrophilic Modification of Au Nanoparticles on the Gold Electrode of QCM by Plasma Deposition for Biomedical Applications
Current Nanoscience Chemokines and Breast Cancer: A Gateway to Revolutionary Targeted Cancer Treatments?
Current Medicinal Chemistry Are Monocyte, %M and WBC Biomarkers in the First Trimester Screening Test?
New Emirates Medical Journal Targeted Therapy for Advanced Renal Cell Cancer: Cytokines and Beyond
Current Pharmaceutical Design Targeting the Cancer Biomarker CD47: A Review on the Diverse Mechanisms of the CD47 Pathway in Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Receptor Selective Synthetic Retinoids as Potential Cancer Chemotherapy Agents
Current Cancer Drug Targets Small Non-Coding RNAs as Biomarkers
Recent Patents on Biomarkers Pharmaceutical Measures to Prevent Doxorubicin-Induced Cardiotoxicity
Mini-Reviews in Medicinal Chemistry Recurrence in Bladder Cancer: A Molecular Dead End?
Current Genomics Photosensitizers Mediated Photodynamic Inactivation Against Virus Particles
Mini-Reviews in Medicinal Chemistry Expression and Prognostic Significance of the MMP Family Molecules in Bladder Cancer
Combinatorial Chemistry & High Throughput Screening Development of a Lung Cancer Model in Wistar Rat and In Silico Screening of its Biomarkers
Current Computer-Aided Drug Design The Effects of Insulin and Insulin-Like Growth Factors on Tumor Vascularization: New Insights of Insulin-Like Growth Factor Family in Cancer
Current Medicinal Chemistry Multifunctional Anti-Cancer Nano-Platforms are Moving to Clinical Trials
Current Drug Metabolism